By Dan Prochilo ( February 14, 2014, 8:30 PM EST) -- A group of pharmacies urged a Tennessee federal judge on Wednesday to reconsider his refusal to certify classes of drug retailers targeting a pay-for-delay deal that suppressed competition to a muscle relaxant made by a unit of Pfizer Inc., saying the similarities among the class members outweighed the differences....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.